GENE ONLINE|News &
Opinion
Blog

2018-03-13| Asia-Pacific

Bainbridge Investments Bids for Healthcare Industry and Advanced Technology in Taiwan

by GeneOnline
Share To

By Joanne Shih

Nick Chini, Chairman and CEO of Bainbridge Investments, a US direct private equity investments company, stated that Bainbridge is optimistic about investing in Taiwan’s healthcare and entertainment industries and plans to participate in bidding for the Gate of Taipei, a skyscraper development in Taipei, in combination with advanced technologies such as artificial intelligence (AI) and augmented reality (AR). In addition, the strong foundation in medical system and healthcare in Taiwan also attracts Bainbridge to deploy Taiwan’s healthcare market.

Nick said that Bainbridge has evaluated the market in Taiwan for many years and decided to set up three major projects in Taiwan, including bidding for the Gate of Taipei real estate investment, entering healthcare industry, and setting up an AI Forum in Taiwan.

Nick asid, “We not only see the Gate of Taipei real estate investment, but also are optimistic about Taiwan’s high-tech and biotechnology industries.” Therefore, the company plans to invest in the healthcare industry in Taiwan intending to merge the technologies in healthcare and medical care with commercial real estate, leisure facilities, restaurants, department stores, or studios to build a giant hospitality development.

Bainbridge Investments has a professional advisory group for all phases of planning, design and construction, and has extensive experience with projects in the United States, Abu Dhabi and China. Considering the Gate of Taipei as not only a national development but also an important hub for Southeast Asia and Asia, Nick has faith in this investment will bring in more opportunities, and will target on the top 500 companies in the world once they take the bid.

Reference
http://bainbridgeinvestments.com
http://www.chinatimes.com/newspapers/20180312000177-260202

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
M&A
CVS Adds Oak Street Health In $10.6 Billion Buy To Boost Primary Care Offerings
2023-02-09
MedTex Summit Asia 2022: Revolutionizing Smart Healthcare with Next Generation Technologies
2022-12-09
35% of Americans May Avoid Seeking Care Due to Concerns Over Healthcare Prices
2022-10-31
LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top